🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase one study to assess the safety of daily dosing of Lactobaci...
Status
Completed
Location
Community of Santa Clara
Start Date
2010-02
Trial ID
NCT00774163
Treatments Being Tested
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
Dyspepsia refers to chronic or recurrent upper gastrointestinal (GI) sympto...
Status
Recruiting
Location
KU Leuven
Start Date
2024-10-01
Trial ID
NCT06482671
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
To compare responses to acute oral doses of ethanol in healthy young adults...
Status
Completed
Location
University of Chicago
Start Date
2019-05-28
Trial ID
NCT03964350
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (...
Status
Completed
Location
Chicago Cornea Consultants, Ltd.
Start Date
2012-10
Trial ID
NCT01666210
Treatments Being Tested
A pilot study to assess the safety and tolerability of oral xanthohumol in ...
Status
Active Not Recruiting
Location
Helfgott Research Institute National University of Natural Medicine
Start Date
2019-08-12
Trial ID
NCT03735420
Treatments Being Tested
The purpose of this study is to confirm the clinical efficacy and the safet...
Status
Completed
Location
Site #102
Start Date
2016-08-02
Trial ID
NCT03004469
Treatments Being Tested